Scar Treatment Market to Reach US$ 13 Bn by 2024

NY - Key companies covered in this report include Smith & Nephew PLC, Merz Inc., Enaltus LLC, Occulus Innovative Sciences Inc., CCA Industries Inc., Cynosure Inc, Avita Medical Limited, Lumenis, Syneron Medical Ltd., Nutramarks Inc., Mölnlycke Health Care, Pacific World Corporation, Valeant Pharmaceuticals International Inc., Shanghai Fosun Pharmaceuticals Ltd. (AC. Alma Lasers), and Beijing Toplaser Technology Company Limited. The report is enriched through identification of company-specific strategies related to mergers and acquisitions, technological developments, product penetration strategies, sourcing, research and development, market consolidation initiatives, and analyses of the various market players’ specific strengths, weaknesses, opportunities, and threats.

Market Dynamics

Growth in revenue generated from the sales of scar treatment products and services is directly attributed to the increasing economic growth and rising personal disposable income levels globally. While treatment of burn scars and keloids is considered to be medically necessary by regulatory bodies, treatment of spot correction, mild-to-medium acne is not deemed as a medical necessity. Rise in affluent population has also been responsible for further fuelling demand for aesthetic corrective procedures such as volume restoration, dermal filling, laser treatments, and wrinkle reduction. Hyaluronic acid based dermal fillers and botulinum type-A injections are prime examples of the same. Markets across the world are also witnessing growth in demand for combination therapeutics in scar treatments, with a view to increase the effectiveness of the procedure and shorten treatment duration.

International regulatory benchmarking for uniform treatment guidelines and shortening of approval times are trends expected to prevail in the industry over the forecast period. This is expected to be accompanied by standardized documentation of clinical evidence of various combination therapeutics related to pharmacovigilance activities.

View Research Methodology@ http://www.persistencemarketresearch.com/market-research/global-scar-treatment-market.asp

Market Segmentation, by Product Type

Based on product type, the overall market has been segmented into topical products, laser products, surface treatment products, and injectable products. The topical product segment is further sub-segmented into creams, gels, oils, and silicone gel sheets. The laser segment has been sub-segmented into CO2, excimer, and pulse-dyed lasers. Within the topical segment, the silicone gel products are expected to witness increased adoption. While silicone gel sheets could find increased application for treating hypertrophic scars and keloids, silicone gels could be used to treat acne. Brand positioning among reputed end-users is a typical marketing strategy being adopted by product manufacturers. Existing brand loyalty among physicians and pharmacists makes it difficult for new entrants to penetrate this market. In this regard, the ‘silicone gel sheet’ sub-segment has been estimated to be valued at US$ 2,443.8 Mn by the end of 2024, registering a moderate CAGR over the forecast period.

Market Segmentation, by Scar Type

Based on scar type, the market has been segmented into atrophic scars, hypertrophic scars and keloids, contractures, and stretch marks. Out of these four scar types, acne is the most common. Treatments for acne include a broad range of products, right from antibiotics to fractional CO2 lasers. Atrophic scar segment has been estimated to be valued at US$ 6,375.7 Mn by the end of 2024. Incidences of acne are estimated to increase over the forecast period due to changing lifestyles, increased consumption of frozen fatty food items, and early onset of aging globally.

A sample of this report is available upon request@ http://www.persistencemarketresearch.com/samples/10819

Market Segmentation, by End User

Based on the end user, the global scar treatment market has been segmented into hospitals, clinics, pharmacies and retail drug stores, and e-commerce. Hospitals are clearly the most availed option by patients worldwide. However, treatment through specialist dermatologists at private clinics is a trend picking up in Brazil and Australia. The clinic's segment is expected to be valued at US$ 3,840.4 Mn by 2024 end, registering a moderate CAGR over the forecast period.

Key Regions

The global scar treatment market has been segmented into five major regions, namely North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. In terms of value, North America market is estimated to be dominant, accounting for over one-third of the total scar treatment market value by 2015 end. Latin America is estimated to emerge as the fastest growing market among all the emerging regions, while revenue from the market in Europe is expected to expand at a healthy CAGR of 4.0% over the forecast period despite the ongoing economic downturn in the region. Over the forecast period, the growth in Europe is expected to be fuelled by the rapidly aging population across all countries in the region.

View Report Table of Contents, Figures, and Tables@ http://www.persistencemarketresearch.com/market-research/global-scar-treatment-market/toc

Persistence Market Research Overview

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

U.S. Sales Office

305 Broadway,7th Floor
New York City, NY 10007
United States
T: +1-646-568-7751
Tollfree: +1 800-961-0353

This release was published on openPR.